Skip to content
Skip to content
Home
About IBPR
Introduction
History
Organization
R & D
Objectives
Research Topics
Platform Technology
Achievements
Cases
Investigators
Investigator
Jointly Appointed Investigator
Contact
Investigators
Research Staff
Administrative Staff
Map
Careers
Technology Services
Introduction
One-stop Early Drug Discovery/Preclinical Services Platform
Lead Compound and Developmental Drug Candidate Evaluation Services Core Facilities
Value-Added MedChem Innovation Center (VMIC)
VMIC
中文首頁
NHRI
Congratulation to Academia Sinica Academician Horace H. Loh, Advisor of IBPR, on receiving 2015 SCBA Lifetime Achievement Award.
IBPR
2015-06-30
2015-12-31
Awards & Honors
Post Views:
588
The novel smallmolecule anticancer drug candidate licensed to SynCore Biotechnology has been approved for the Phase II clinical trial by TFDA and US FDA
Congratulation to the novel anti-diabetic drug candidate DBPR108 of IBPR on receiving Gold Award in Technology Transfer for the 2015 Taipei Biotech Award
Comments are closed.
Home
News & Events
Awards & Honors
